好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Unmasking Giant Cell Arteritis: A Rare Clinical Presentation
Headache
P2 - Poster Session 2 (11:45 AM-12:45 PM)
15-012
To highlight the importance of maintaining clinical suspicion for Giant Cell Arteritis despite normal inflammatory markers and atypical presentation.

Giant Cell Arteritis (GCA) is a potentially vision-threatening condition that often presents with symptoms like new-onset headaches, visual disturbances, and elevated inflammatory markers like ESR and CRP. However, challenges with diagnosis arise when patients exhibit atypical symptoms. Early recognition is crucial to prevent irreversible vision loss. We report a rare and diagnostically challenging case of GCA with atypical clinical presentation, which initially suggested an alternative ocular etiology.

N/A

A 59-year-old male with a history of left internal carotid artery aneurysm post-stent, hyperlipidemia, and peripheral vascular disease presented with a 3-month history of intermittent, left-sided headaches, and neck pain. Over the course of three days, he developed worsening photophobia and blurred vision in the left eye. Lab work up showed normal ESR and CRP levels, and unremarkable MRI brain and cervical spine imaging. Initial ophthalmologic evaluation suggested floppy eyelid syndrome as the cause of his visual symptoms. Treatment for ocular issues did not alleviate his headaches, raising suspicion for GCA. Temporal artery duplex ultrasound revealed bilateral temporal artery inflammation with the classic hypoechoic halo sign, confirming the diagnosis. Prednisone 60 mg daily was initiated, leading to symptom improvement. The overlapping ocular condition and prolonged nature of the headache delayed the diagnosis.

This rare case highlights the importance of having high index of suspicion for Giant Cell Arteritis, when presented with normal inflammatory markers and atypical clinical presentation. Timely recognition and comprehensive evaluation are prudent to prevent irreversible vision loss.

Authors/Disclosures
Adrian J. Diaz, DO (Memorial Healthcare System)
PRESENTER
Dr. Diaz has nothing to disclose.
Byron D. Cheon, MD Dr. Cheon has nothing to disclose.
Emaan Fawad, Other Miss Fawad has nothing to disclose.
Fajar Fawad, Other Miss Fawad has nothing to disclose.
Sadia Waheed, MBBS Dr. Waheed has nothing to disclose.
Fawad Yousuf, MBBS Dr. Yousuf has nothing to disclose.